• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

益生菌亚种可预防香烟烟雾引起的小鼠炎症。

Probiotic subsp. Protects against Cigarette Smoke-Induced Inflammation in Mice.

机构信息

Priority Research Centre for Healthy Lungs and Immune Health Research Program, Hunter Medical Research Institute and The University of Newcastle, Callaghan, NSW 2308, Australia.

Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, NSW 2007, Australia.

出版信息

Int J Mol Sci. 2022 Dec 23;24(1):252. doi: 10.3390/ijms24010252.

DOI:10.3390/ijms24010252
PMID:36613693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9820259/
Abstract

are prominent gut commensals that produce the short-chain fatty acid (SCFA) acetate, and they are often used as probiotics. Connections between the gut and the lung, termed the gut-lung axis, are regulated by the microbiome. The gut-lung axis is increasingly implicated in cigarette smoke-induced diseases, and cigarette smoke exposure has been associated with depletion of species. In this study, we assessed the impact of acetate-producing subsp. (WT) and a mutant strain with an impaired acetate production capacity (MUT) on cigarette smoke-induced inflammation. The mice were treated with WT or MUT subsp. and exposed to cigarette smoke for 8 weeks before assessments of lung inflammation, lung tissue gene expression and cecal SCFAs were performed. Both strains of subsp. reduced lung inflammation, inflammatory cytokine expression and adhesion factor expression and alleviated cigarette smoke-induced depletion in caecum butyrate. Thus, the probiotic administration of subsp. irrespective of its acetate-producing capacity, alleviated cigarette smoke-induced inflammation and the depletion of cecal butyrate levels.

摘要

是肠道中突出的共生菌,它们可以产生短链脂肪酸(SCFA)乙酸盐,常被用作益生菌。肠道和肺部之间的联系,被称为肠肺轴,受微生物组的调节。肠肺轴与香烟烟雾引起的疾病的关系越来越密切,并且香烟烟雾暴露与 物种的消耗有关。在这项研究中,我们评估了产生乙酸盐的 亚种(WT)和一种产乙酸能力受损的突变株(MUT)对香烟烟雾诱导的炎症的影响。用 WT 或 MUT 亚种处理小鼠,并在进行肺炎症、肺组织基因表达和盲肠 SCFA 评估之前,让其暴露于香烟烟雾 8 周。两种 亚种菌株都减轻了肺炎症、炎症细胞因子表达和黏附因子表达,并缓解了香烟烟雾诱导的盲肠丁酸盐消耗。因此,无论其产乙酸能力如何, 亚种的益生菌给药都减轻了香烟烟雾诱导的炎症和盲肠丁酸盐水平的消耗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f26a/9820259/1a88f883e19a/ijms-24-00252-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f26a/9820259/50277bc0ae34/ijms-24-00252-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f26a/9820259/573b17412148/ijms-24-00252-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f26a/9820259/1a88f883e19a/ijms-24-00252-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f26a/9820259/50277bc0ae34/ijms-24-00252-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f26a/9820259/573b17412148/ijms-24-00252-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f26a/9820259/1a88f883e19a/ijms-24-00252-g003.jpg

相似文献

1
Probiotic subsp. Protects against Cigarette Smoke-Induced Inflammation in Mice.益生菌亚种可预防香烟烟雾引起的小鼠炎症。
Int J Mol Sci. 2022 Dec 23;24(1):252. doi: 10.3390/ijms24010252.
2
Safety and intestinal microbiota modulation by the exopolysaccharide-producing strains Bifidobacterium animalis IPLA R1 and Bifidobacterium longum IPLA E44 orally administered to Wistar rats.经口给予产胞外多糖双歧杆菌动物亚种 IPLA R1 和长双歧杆菌 IPLA E44 对 Wistar 大鼠的安全性及肠道微生物群调节作用。
Int J Food Microbiol. 2011 Jan 5;144(3):342-51. doi: 10.1016/j.ijfoodmicro.2010.10.016.
3
Exopolysaccharides Produced by subsp. YS108R Ameliorates DSS-Induced Ulcerative Colitis in Mice by Improving the Gut Barrier and Regulating the Gut Microbiota.亚氏乳杆菌 YS108R 产生的胞外多糖通过改善肠道屏障和调节肠道微生物群来缓解 DSS 诱导的小鼠溃疡性结肠炎。
J Agric Food Chem. 2024 Apr 3;72(13):7055-7073. doi: 10.1021/acs.jafc.3c06421. Epub 2024 Mar 23.
4
subsp. Remodeled and Phosphatidylserine Levels and Ameliorated Intestinal Disorders and liver Metabolic Abnormalities Induced by High-Fat Diet.亚属。重塑和磷脂酰丝氨酸水平,并改善高脂肪饮食引起的肠道紊乱和肝脏代谢异常。
J Agric Food Chem. 2020 Apr 22;68(16):4632-4640. doi: 10.1021/acs.jafc.0c00717. Epub 2020 Apr 10.
5
subsp. FJSYZ1M3 ameliorates DSS-induced colitis by maintaining the intestinal barrier, regulating inflammatory cytokines, and modifying gut microbiota.亚种 FJSYZ1M3 通过维持肠道屏障、调节炎症细胞因子和改变肠道微生物群来改善 DSS 诱导的结肠炎。
Food Funct. 2023 Jan 3;14(1):354-368. doi: 10.1039/d2fo03263e.
6
Bifidobacterium longum subsp. longum 5 attenuates intestinal injury against irinotecan-induced mucositis in mice.长双歧杆菌亚种 longum 5 减轻伊立替康诱导的小鼠黏膜炎的肠道损伤。
Life Sci. 2022 Jan 15;289:120243. doi: 10.1016/j.lfs.2021.120243. Epub 2021 Dec 16.
7
Both viable subsp. B8762 and heat-killed cells alleviate the intestinal inflammation of DSS-induced IBD rats.活的 B8762 亚种和热杀死的细胞都能缓解 DSS 诱导的 IBD 大鼠的肠道炎症。
Microbiol Spectr. 2024 Jun 4;12(6):e0350923. doi: 10.1128/spectrum.03509-23. Epub 2024 Apr 22.
8
The effect of probiotic supplementation on the gut microbiota of preterm infants.益生菌补充对早产儿肠道微生物群的影响。
J Med Microbiol. 2021 Aug;70(8). doi: 10.1099/jmm.0.001403.
9
A ropy exopolysaccharide producing strain Bifidobacterium longum subsp. longum YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation.产黏态胞外多糖双歧杆菌长亚种 YS108R 通过维持黏膜屏障和调节肠道微生物群缓解 DSS 诱导的结肠炎。
Food Funct. 2019 Mar 20;10(3):1595-1608. doi: 10.1039/c9fo00014c.
10
Assessment of the synbiotic properites of human milk oligosaccharides and Bifidobacterium longum subsp. infantis in vitro and in humanised mice.评估人乳寡糖和长双歧杆菌亚种。婴儿在体外和人源化小鼠中的共生特性。
Benef Microbes. 2017 Apr 26;8(2):281-289. doi: 10.3920/BM2016.0138. Epub 2017 Jan 24.

引用本文的文献

1
Chronic obstructive pulmonary disease: in-depth analysis of microbiota association and innovative prevention and treatment approaches from the gut-lung axis perspective.慢性阻塞性肺疾病:从肠-肺轴角度对微生物群关联及创新防治方法的深入分析
Front Immunol. 2025 Jul 30;16:1549865. doi: 10.3389/fimmu.2025.1549865. eCollection 2025.
2
Nutritional Support of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病的营养支持
Nutrients. 2025 Mar 26;17(7):1149. doi: 10.3390/nu17071149.
3
Reducing severity of inflammatory bowel disease through colonization of Lactiplantibacillus plantarum and its extracellular vesicles release.

本文引用的文献

1
Cross-feeding interactions between human gut commensals belonging to the and genera when grown on dietary glycans.在膳食聚糖上生长时,属于 和 属的人类肠道共生菌之间的交叉喂养相互作用。 (原文中两个属名处信息缺失)
Microbiome Res Rep. 2022 Mar 18;1(2):12. doi: 10.20517/mrr.2021.05. eCollection 2022.
2
Beneficial effects of CCL8 inhibition at lipopolysaccharide-induced lung injury.CCL8抑制对脂多糖诱导的肺损伤的有益作用。
iScience. 2022 Dec 22;25(12):105520. doi: 10.1016/j.isci.2022.105520. Epub 2022 Nov 7.
3
Current Nanomedicine for Targeted Vascular Disease Treatment: Trends and Perspectives.
通过植物乳杆菌的定殖及其细胞外囊泡的释放来降低炎症性肠病的严重程度。
J Nanobiotechnology. 2025 Mar 20;23(1):227. doi: 10.1186/s12951-025-03280-7.
4
The gut microbiota-SCFA-inflammation axis in patients with AECOPD.慢性阻塞性肺疾病急性加重期患者的肠道微生物群-短链脂肪酸-炎症轴
PLoS One. 2025 Jan 9;20(1):e0312606. doi: 10.1371/journal.pone.0312606. eCollection 2025.
5
The role and mechanism of gut-lung axis mediated bidirectional communication in the occurrence and development of chronic obstructive pulmonary disease.肠-肺轴介导的双向通讯在慢性阻塞性肺疾病发生发展中的作用及其机制。
Gut Microbes. 2024 Jan-Dec;16(1):2414805. doi: 10.1080/19490976.2024.2414805. Epub 2024 Oct 24.
6
Gut Microbiota Modulation in the Management of Chronic Obstructive Pulmonary Disease: A Literature Review.慢性阻塞性肺疾病管理中肠道微生物群的调节:文献综述
Cureus. 2024 Aug 14;16(8):e66875. doi: 10.7759/cureus.66875. eCollection 2024 Aug.
7
Neonatal Chlamydia muridarum respiratory infection causes neuroinflammation within the brainstem during the early postnatal period.新生仓鼠肺炎衣原体呼吸道感染会导致新生后早期的脑干神经炎症。
J Neuroinflammation. 2024 Jun 15;21(1):158. doi: 10.1186/s12974-024-03150-3.
8
Exploratory analysis on the association of dietary live microbe and non-dietary prebiotic/probiotic intake with serum cotinine levels in the general adult population.一般成年人群中膳食活菌与非膳食益生元/益生菌摄入量与血清可替宁水平关联的探索性分析。
Front Nutr. 2024 May 28;11:1405539. doi: 10.3389/fnut.2024.1405539. eCollection 2024.
9
JS-3 Isolated from "Jiangshui" Ameliorates Hyperuricemia by Regulating Gut Microbiota and iTS Metabolism.从“江水”中分离出的JS-3通过调节肠道微生物群及其代谢改善高尿酸血症。
Foods. 2024 Apr 29;13(9):1371. doi: 10.3390/foods13091371.
10
Application of Microbiome-Based Therapies in Chronic Respiratory Diseases.基于微生物组的疗法在慢性呼吸系统疾病中的应用。
J Microbiol. 2024 Mar;62(3):201-216. doi: 10.1007/s12275-024-00124-1. Epub 2024 Apr 18.
当前靶向血管疾病治疗的纳米医学:趋势与展望。
Int J Mol Sci. 2022 Oct 17;23(20):12397. doi: 10.3390/ijms232012397.
4
Gut bacteria alleviate smoking-related NASH by degrading gut nicotine.肠道细菌通过降解肠道尼古丁缓解与吸烟有关的 NASH。
Nature. 2022 Oct;610(7932):562-568. doi: 10.1038/s41586-022-05299-4. Epub 2022 Oct 19.
5
Antiviral Responses of Tissue-resident CD49a Lung Natural Killer Cells Are Dysregulated in Chronic Obstructive Pulmonary Disease.组织驻留 CD49a 肺自然杀伤细胞的抗病毒反应在慢性阻塞性肺疾病中失调。
Am J Respir Crit Care Med. 2023 Mar 1;207(5):553-565. doi: 10.1164/rccm.202205-0848OC.
6
Smoking-induced microbial dysbiosis in health and disease.吸烟引起的健康和疾病相关的微生物失调。
Clin Sci (Lond). 2022 Sep 30;136(18):1371-1387. doi: 10.1042/CS20220175.
7
Adverse roles of mast cell chymase-1 in COPD.肥大细胞糜酶-1在 COPD 中的不良作用。
Eur Respir J. 2022 Dec 8;60(6). doi: 10.1183/13993003.01431-2021. Print 2022 Dec.
8
Airway and parenchymal transcriptomics in a novel model of asthma and COPD overlap.哮喘和慢性阻塞性肺疾病重叠新模型中的气道和实质转录组学
J Allergy Clin Immunol. 2022 Oct;150(4):817-829.e6. doi: 10.1016/j.jaci.2022.04.032. Epub 2022 May 25.
9
Targeting intercellular adhesion molecule-1 (ICAM-1) to reduce rhinovirus-induced acute exacerbations in chronic respiratory diseases.针对细胞间黏附分子-1(ICAM-1)以减少呼吸道合胞病毒引起的慢性呼吸系统疾病的急性加重。
Inflammopharmacology. 2022 Jun;30(3):725-735. doi: 10.1007/s10787-022-00968-2. Epub 2022 Mar 22.
10
Recent Development of Probiotic for Treating Human Diseases.用于治疗人类疾病的益生菌的最新进展。
Front Bioeng Biotechnol. 2021 Dec 22;9:770248. doi: 10.3389/fbioe.2021.770248. eCollection 2021.